Linklaters advised the EIC Fund (European Innovation Council Fund) on the deal.Created in 2014, XENOTHERA is a French biotech developing a technological platform of glyco-humanized polyclonal…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now